Neochem Bio Ipo
Neochem Bio IPO Review & Key Points
Review:
IPO Lead Managers aka Merchant Bankers
Vivro Financial Services Pvt. Ltd.
| Application | Lot Size | Shares | Amount |
| Retail Minimum | 2 | 2,400 | ₹2,35,200 |
| Retail Maximum | 2 | 2,400 | ₹2,35,200 |
| S-HNI Minimum | 3 | 3,600 | ₹3,52,800 |
| S-HNI Maximum | 8 | 9,600 | ₹9,40,800 |
| B-HNI Minimum | 9 | 10,800 | ₹10,58,400 |
| Investor Category | Share Offered | -% Shares |
| Anchor Investor | – Shares | -% |
| QIB (Ex. Anchor) | – Shares | 50% |
| NII Shares Offered | – Shares | 15% |
| Retail Shares Offered | – Shares | 35% |
| Anchor Bidding Date | December 1, 2025 |
| Anchor Investors List | |
| Shares Offered | [.] Shares |
| Anchor Size | [.] Cr. |
| lock-in period end date 50% shares (30 Days) | January 4, 2026 |
| lock-in period end date 50% shares (90 Days) | March 5, 2026 |
| IPO Open Date: | December 2, 2025 |
| IPO Close Date: | December 4, 2025 |
| Basis of Allotment: | December 5, 2025 |
| Refunds: | December 8, 2025 |
| Credit to Demat Account: | December 8, 2025 |
| IPO Listing Date: | December 9, 2025 |
| IPO Bidding Cut-off Time: | December 4, 2025 – 5 PM |
| Particular | Shares | % Share |
| Promoter Holding Pre Issue | 1,25,31,953 | 91.12% |
| Promoter Holding Post Issue | 1,71,20,753 | 66.7% |
| Purpose | Crores |
| Funding the long-term working capital requirements of the Company | ₹23.90 |
| Repayment/prepayment, in full or part, of all or certain outstanding borrowings availed by the Company | ₹10.00 |
| General Corporate Purpose | ₹- |
| Period Ended | Revenue | Expense | PAT | Assets |
| 2023 | ₹48.79 | ₹47.27 | ₹1.07 | ₹50.60 |
| 2024 | ₹62.01 | ₹59.34 | ₹1.80 | ₹64.06 |
| 2025 | ₹86.15 | ₹75.89 | ₹7.75 | ₹78.89 |
| September 2025 | ₹47.18 | ₹39.85 | ₹5.48 | ₹96.49 |
| KPI | Values |
| ROE: | 48.82% |
| ROCE: | 41.67% |
| EBITDA Margin: | 15.58% |
| PAT Margin: | 9.00% |
| Debt to equity ratio: | 1.80 |
| Earning Per Share (EPS): | ₹6.64 (Basic) |
| Price/Earning P/E Ratio: | N/A |
| Return on Net Worth (RoNW): | 48.82% |
| Net Asset Value (NAV): | ₹16.91 |
| Company | EPS | PE Ratio | RoNW % | NAV | Income |
| Rossari Biotech Limited | 24.66 | 26.00 | 5.78% | 226.05 | 1,129.82 Cr. |
| Indian Emulsifiers Limited | 11.40 | 8.83 | 11.78% | 75.54 | 76.98 Cr. |
| IPO Open Date | December 2, 2025 |
| IPO Close Date | December 4, 2025 |
| Face Value | ₹10 Per Equity Share |
| IPO Price Band | ₹93 to ₹98 Per Share |
| Issue Size | Approx ₹44.97 Crores |
| Fresh Issue | Approx ₹44.97 Crores |
| Issue Type | Book Built Issue |
| IPO Listing | NSE SME |
| DRHP Draft Prospectus | |
| RHP Draft Prospectus |